Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04064541 · ClinicalTrials.gov registry record · NA

Virtual Visits to Optimize Research Trial Offerings to HF Patients

A NA study of Heart Failure With Preserved Ejection Fraction and Heart Failure, Systolic, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
94
Enrollment target
1
Study location

NCT04064541 is a NA study of Heart Failure With Preserved Ejection Fraction and Heart Failure, Systolic that has completed, run by The Cleveland Clinic. The registered enrollment target is 94 participants, below the 2,286-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04064541, a NA study of Heart Failure With Preserved Ejection Fraction and Heart Failure, Systolic, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target
1
Study location

Study Summary

This pilot study seeks to understand if distance health technology with virtual visits hold the key to improving access for patients who wish to partake in clinical trials clearing barriers to enrollment.

Interventions

  • OTHER Virtual Visit

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2019-08-01
Est. Completion 2020-03-30
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT04064541

The ClinicalTrials.gov registry entry for NCT04064541 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,286-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (96% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Virtual Visit is the first listed.

NCT04064541 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04064541 about?

NCT04064541 is a clinical study titled "Virtual Visits to Optimize Research Trial Offerings to HF Patients". This pilot study seeks to understand if distance health technology with virtual visits hold the key to improving access for patients who wish to partake in clinical trials clearing barriers to enrollment.

What is the current status of trial NCT04064541?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2019-08-01. Estimated completion is 2020-03-30.

What conditions does trial NCT04064541 study?

This clinical trial studies the following conditions: Heart Failure With Preserved Ejection Fraction, Heart Failure, Systolic.

What interventions are being tested in trial NCT04064541?

The interventions under investigation include: Virtual Visit (OTHER).

Who is sponsoring clinical trial NCT04064541?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04064541 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure With Preserved Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.